Next Article in Journal
Determinants of Response to Immune Checkpoint Blockade in Pleural Mesothelioma: Molecular, Immunological, and Clinical Perspectives
Next Article in Special Issue
Cost Analysis of PSMA-PET in the PROSPET-BX Trial
Previous Article in Journal
In Vitro and In Vivo Efficacy of Romidepsin Alone and in Addition to Standard of Care for Treatment of Ewing Sarcoma
Previous Article in Special Issue
Digital Twins for Radiopharmaceutical Dosimetry: PBPK Modelling of [177Lu]Lu-rhPSMA-10.1 in a Preclinical mCRPC Model
 
 
Review

Article Versions Notes

Cancers 2025, 17(24), 4019; https://doi.org/10.3390/cancers17244019
Action Date Notes Link
article html file updated 17 December 2025 11:14 CET Original file https://www.mdpi.com/2072-6694/17/24/4019/html
article pdf uploaded. 17 December 2025 11:11 CET Version of Record https://www.mdpi.com/2072-6694/17/24/4019/pdf
article xml uploaded. 17 December 2025 11:11 CET Update https://www.mdpi.com/2072-6694/17/24/4019/xml
article xml file uploaded 17 December 2025 11:11 CET Original file -
Back to TopTop